PD-L1 positivity (evaluated using Rabbit Anti-Human Monoclonal Antibody (clone SBC-992, Sina Biotech and defined as expression above 1% in tumor cells and over 5% in inflammatory cells)) was detected in 57.15% and 39.28% of cases, respectively. This evidence concerns the gene CD274 and neoplasm.